Aptose Biosciences Inc.
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Product Pipeline
Overview
Tuspetinib for AML
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
Posters & Presentations
Clinical Trials
Overview
Luxeptinib for CLL & NHL
Luxeptinib for AML
Tuspetinib (HM43239) for AML
Expanded Access
News
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
Join Us
Values & Culture
Perks & Benefits
Explore Careers
Contact
Posters & Presentations
Product Pipeline
Product Pipeline
Overview
Tuspetinib for AML
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
Posters & Presentations
All
Poster
Presentation
May 2, 2013
Poster
2013 AACR PD Studies
2013 AACR PD Studies:
View Poster
May 1, 2013
Poster
2012 AACR Tumor Immunology Conference
2012 AACR Tumor Immunology Conference:
View Poster
May 1, 2013
Poster
2013 EEC ESMO Phase I Poster
2013 EEC ESMO Phase I Poster:
View Poster
May 1, 2012
Poster
2012 AACR Poster Combination Studies
2012 AACR Poster Combination Studies:
View Poster
Previous
1
2
3
4
5
6
7